Sapphire Therapeutics, Inc. Announces Promotions and New Appointment to Management Team
8/9/2007 8:45:15 AM
BRIDGEWATER, NJ--(MARKET WIRE)--Aug 9, 2007 -- Sapphire Therapeutics, Inc., a private biopharmaceutical company that develops compounds acting within the ghrelin pathway as treatments for metabolic, oncologic, and gastrointestinal diseases, today announced two management promotions and a new appointment that reinforce the company's team of pharmaceutical development experts who are advancing development of the company's growing therapeutic pipeline.
comments powered by